Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T
Identification of the main interface hot-spot of AGT-Mi. Expression and purification of an engineered soluble monomeric form of AGT-Mi. Determination of the kinetics of the dimerization process of monomeric AGT-Mi. Monomeric AGT-Mi binds PLP but does not display catalytic activity. Proposal of a model explaining the mistargeting of the variants F152I-Mi and I244T-Mi.